The Role of Palmaris Muscle Tendon in Mitral Valve Annulus Reconstruction: A Novel Technique for Mitral Valve Repair
Background: Autogenous tissue for heart valve repair is limited to pericardium and fascia lata. Prosthetic annuloplasty rings have limitations and are expensive. No previous cadaveric study has documented autotransplantation of forearm tendons for mitral valve repair. The purposes of this anatomical study were (1) to determine the feasibility of using tendons for annular reconstruction during mitral valve repair (band or ring shape) and (2) to compare the metric dimensions and gross morphology with those of prosthetic rings.
Methods: The palmaris tendon (PM) (n = 7) was harvested from forearms of human cadavers and prepared in the dissecting room. The tendon was incorporated along the valve annulus. Surgery consisted of mitral valve annuloplasty performed with an undersized and a complete tendon.
Results: On gross handling PM tissue was morphologically resilient. Preparation and use of PM for annuloplasty were feasible. Anatomical reconstruction of the annulus with autogenous tissue using this tendon also was feasible. The annulus behaved as a flexible ring that allowed for improved atrioventricular continuity. Complete (n = 7) and partial (n = 7) annuloplasty rings were constructed. Metric dimensions were similar to those of prosthetic rings.
Conclusion: PM is a suitable novel autogenous tissue that can be harvested together with the radial artery and has direct relevance in ischemic mitral valve regurgitation. These tendons can be easily utilized to achieve results similar to those of pericardial reconstruction and prosthetic annuloplasty rings. The tissue is readily available from the patient, and no extra cost is incurred. Further chemical studies in the human subjects are warranted.
Ionescu MI, Ross DN, Wooler GH, Deac R, Ray D. 1970. Replacement of heart valves with autologous fascia lata: surgical technique. Br J Surg 57:437-42.nLam DS, Ng JS, Cheng GP, Li RT. 1998. Autogenous palmaris longus tendon as frontalis suspension material for ptosis correction in children. Am J Ophthalmol 126:109-15.nMcCarthy JG, ed. 1990. Plastic Surgery. Vol 1. Philadelphia: WB Saunders; 535-6. Schechtman H, Bader DL. 2002. Fatigue damage of human tendons. J Biomech 35:347-53.nBrand PW. 1961. Tendon grafting: illustrated by a new operation for intrinsic paralysis of the fingers. J Bone Joint Surg 43B:444-53.nChachques JC, Acar C, Latremouille C, et al. 1990. Absorbable rings for pediatric valvuloplasty: preliminary study. Circulation 82(suppl):IV82-8.nDeloche A, Jebara VA, Relland JY, et al. 1990. Valve repair with Carpentier techniques: the second decade. J Thorac Cardiovasc Surg 99:990-1001.nDickson JB, Major MD. 1986. The use of a pedal extensor tendon in frontalis suspension surgery. Ophthalmic Surg 17:581-3.nDietl CA, Benoit CH. 1995. Radial artery graft for coronary revascularization: technical considerations. Ann Thorac Surg 60:102-9.nEnriquez-Sarano M, Schaff HV, Frye RL. 2003. Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair. Circulation 22;108:253-6.nEnriquez-Sarano M, Schaff HV, Orszulak TA, Takij AJ, Bailey KR, Frye RL. 1995. Valve repair improves the outcome of surgery for mitral regurgitation: a multivariate analysis. Circulation 91:1022-8.nFrater RW, Gabbay S, Shore D, Factor S, Strom J. 1983. Reproducible replacement of elongated or ruptured mitral valve chordae. Ann Thorac Surg 35:14-28.nGelberman RH, Vandeberg JS, Manske PR, Akeson WH. 1985. The early stages of flexor tendon healing: a morphologic study of the first fourteen days. J Hand Surg 10A:776-84.nGillinov AM, Wierup PN, Blackstone EH, et al. 2001. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 122:1125-41.nGray H. 1918. Anatomy of the Human Body. Philadelphia: Lea & Febiger. Available at: http://www.bartleby.com/107.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).